Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × alirocumab × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 100 Specimen Handling 97 pembrolizumab 94 Cyclophosphamide 90 Radiotherapy 75 Biopsy 68 venetoclax 66 Nivolumab 55 Carboplatin 50 Cisplatin 49 fludarabine 47 Dexamethasone 47 Radiosurgery 45 Blood Specimen Collection 42 Standard of Care 41 Paclitaxel 41 Surveys and Questionnaires 38 Rituximab 38 Drug Therapy 37 Azacitidine 36 Oxaliplatin 34 Gemcitabine 34 Bevacizumab 34 durvalumab 31 Radiation 30 Ipilimumab 30 Cytarabine 30 fludarabine phosphate 28 X-Rays 28 Fluorouracil 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡